Ads
related to: memorial sloan kettering cancer centermskcc.org has been visited by 100K+ users in the past month
cancer.osu.edu has been visited by 10K+ users in the past month
Search results
NIH, MSKCC researchers publish AI model for predicting immunotherapy responses
FierceBiotech· 1 day agoResearchers at the National Institutes of Health and Memorial Sloan Kettering Cancer Center said ...
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 1 day agoA study of 75 women with breast cancer by researchers from the Memorial Sloan Kettering Cancer ...
New bowel tumor drug helped cure cancer in 100% of cases
BGR· 1 day agoA drug called Jemperli (dostarlimab) showed impressive results in a phase 2 trial at the Memorial ...
Opinion: The Fauci witch hunt intensifies while the next threat looms
CNN.com· 1 day agoEditor’s Note: Kent Sepkowitz is a physician and infectious disease expert at Memorial Sloan ...
Scientists develop AI tool to predict how cancer patients will respond to immunotherapy
Medical Xpress· 2 days agoNCI is part of the National Institutes of Health. Currently, two predictive biomarkers are approved by the Food and Drug Administration...
Immunotherapy bowel cancer drug works for 100% of patients
dpa international via Yahoo News· 3 days agoAn immunotherapy drug could spare bowel cancer patients the need for surgery after results showed it...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 days agoEvorpacept in combination with PADCEV®, an approved antibody-drug conjugate (“ADC”), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast ...
GSK reports 100% response in rectal cancer study with Jemperli By Investing.com
Investing.com· 2 days agoGSK plc (LSE/NYSE: LON:GSK) has shared updated results from a phase II study conducted in...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 2 days agoThe drug candidate was found to be 100% effective in treating all patients who were enrolled in the...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 6 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Ad
related to: memorial sloan kettering cancer centermskcc.org has been visited by 100K+ users in the past month
